CRISPR Functional Genomics Symposium

Explore entire pathways, from gene to phenotype

June 28 - July 1, 2021

10x_Logos_Web_10x_and_Millipore.png

Though unraveling gene function within pathways and discovering drug targets that impact phenotypes has been challenging, innovative single cell CRISPR screens are now enabling researchers to discover novel insights into these gene pathways. Explore what’s possible with scalable, high resolution functional genomic screens at the CRISPR Functional Genomics Symposium, sponsored by 10x Genomics and MilliporeSigma.

Hear from leading scientists using single cell CRISPR screens to characterize the genes and non-coding regulatory elements involved in cell fate determination, cancer and neurodevelopmental disease risk, and therapeutic response and resistance. Register today to watch the recordings.

Agenda


10x_Headshots_Speakers_Ben_Borgo_MilliporeSigma.png

Talk 1: Enhancing the resolution of your CRISPR screens with single cell compatibility
Benjamin Borgo, PhD
Head of Portfolio Management and Product Development, Genome Engineering & Modulation
MilliporeSigma

10x_Headshots_Speakers_Jason_Koth.png

Talk 2: Connecting genes to phenotypes with single cell CRISPR screens
Jason Koth
Product Manager, Single Cell
10x Genomics


10x_Headshots_Speakers_David_Chen_City_of_Hope.png

sc-Tiling: Characterization of gene function using single cell CRISPR tiling screen
David Chen, PhD
Assistant Professor, Department of Systems Biology
City of Hope


10x_Headshots_Speakers_Robi_Mitra_WUSTL.png

Connecting rare mutations to common pathways
Rob Mitra, PhD
Professor, Departments of Genetics & Computational Biology
Washington University School of Medicine in St. Louis


10x_Headshots_Speakers_Sean_McCutcheon.png

CRISPR gene activation screens to identify master regulators of neuronal cell fate
Sean McCutcheon
Graduate Researcher, Biomedical Engineering
Duke University




The life science business ​of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. ​and Canada.

Add content here.